Breaking: World’s Largest Pharmaceutical Company, Eli Lilly, Acquires 5-MeO-DMT Developer AtaiBeckley for Up to $3.8 billion By Watertime - July 16, 2026 0 Post Content RELATED ARTICLESMORE FROM AUTHOR Psychedelic Policy Briefing: Week of July 13th, 2026 Backed by $11M NIDA Grant, Harvard Moves Forward on Ibogaine for Opioid Use Disorder Research Keeping Up with the Feds: From FDA to HRSA, Washington Backs Psychedelics
